 ANN ARBOR, MI ACCESSWIRE December 18, 2020 ENDRA Life Sciences Inc. ENDRA NASDAQ:NDRA, a developer of enhanced ultrasound technologies, today reported the closing of its previously announced underwritten public offering of 7,143,000 shares of common stock at an offering price of 0.70 per share. In connection with the offering, the underwriter exercised its over-allotment option to purchase an additional 714,286 shares of common stock at the public offering price, less the underwriting discount, in full. 